Global PD-1 and PDL-1 Inhibitors Market Research Report 2024(Status and Outlook)
Report Overview
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
This report provides a deep insight into the global PD-1 and PDL-1 Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PDL-1 Inhibitors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PDL-1 Inhibitors market in any manner.
Global PD-1 and PDL-1 Inhibitors Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline plc
Bristol-Myers Squibb Company
Arcus Biosciences, Inc.
Agenus Inc
F. Hoffmann-La Roche Ltd
Astra Zeneca PLC
Beigene Ltd
Incyte Corporation
Biocad
CStone Pharmaceuticals
Ono Pharmaceutical
Merck
Shanghai Junshi Bioscience Co. Ltd
Shanghai Henlius Biotech, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Market Segmentation (by Type)
Pembrolizumab
Nivolumab
Atezolizumab
Durvalumab
Avelumab
Market Segmentation (by Application)
Stomach Cancer
Liver Cancer
Kidney Ccancer
Bladder Cancer
Cervical Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 and PDL-1 Inhibitors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
This report provides a deep insight into the global PD-1 and PDL-1 Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PDL-1 Inhibitors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PDL-1 Inhibitors market in any manner.
Global PD-1 and PDL-1 Inhibitors Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline plc
Bristol-Myers Squibb Company
Arcus Biosciences, Inc.
Agenus Inc
F. Hoffmann-La Roche Ltd
Astra Zeneca PLC
Beigene Ltd
Incyte Corporation
Biocad
CStone Pharmaceuticals
Ono Pharmaceutical
Merck
Shanghai Junshi Bioscience Co. Ltd
Shanghai Henlius Biotech, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Market Segmentation (by Type)
Pembrolizumab
Nivolumab
Atezolizumab
Durvalumab
Avelumab
Market Segmentation (by Application)
Stomach Cancer
Liver Cancer
Kidney Ccancer
Bladder Cancer
Cervical Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the PD-1 and PDL-1 Inhibitors Market
- Overview of the regional outlook of the PD-1 and PDL-1 Inhibitors Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-1 and PDL-1 Inhibitors Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PD-1 and PDL-1 Inhibitors
1.2 Key Market Segments
1.2.1 PD-1 and PDL-1 Inhibitors Segment by Type
1.2.2 PD-1 and PDL-1 Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 AND PDL-1 INHIBITORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 and PDL-1 Inhibitors Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 AND PDL-1 INHIBITORS MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 and PDL-1 Inhibitors Sales by Manufacturers (2019-2024)
3.2 Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PDL-1 Inhibitors Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 and PDL-1 Inhibitors Sales Sites, Area Served, Product Type
3.6 PD-1 and PDL-1 Inhibitors Market Competitive Situation and Trends
3.6.1 PD-1 and PDL-1 Inhibitors Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PDL-1 Inhibitors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 AND PDL-1 INHIBITORS INDUSTRY CHAIN ANALYSIS
4.1 PD-1 and PDL-1 Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 AND PDL-1 INHIBITORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 AND PDL-1 INHIBITORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2019-2024)
6.3 Global PD-1 and PDL-1 Inhibitors Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 and PDL-1 Inhibitors Price by Type (2019-2024)
7 PD-1 AND PDL-1 INHIBITORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PDL-1 Inhibitors Market Sales by Application (2019-2024)
7.3 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2024)
8 PD-1 AND PDL-1 INHIBITORS MARKET SEGMENTATION BY REGION
8.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PDL-1 Inhibitors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PDL-1 Inhibitors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PDL-1 Inhibitors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline plc
9.1.1 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Basic Information
9.1.2 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Overview
9.1.3 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Market Performance
9.1.4 GlaxoSmithKline plc Business Overview
9.1.5 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors SWOT Analysis
9.1.6 GlaxoSmithKline plc Recent Developments
9.2 Bristol-Myers Squibb Company
9.2.1 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Basic Information
9.2.2 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Overview
9.2.3 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Market Performance
9.2.4 Bristol-Myers Squibb Company Business Overview
9.2.5 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors SWOT Analysis
9.2.6 Bristol-Myers Squibb Company Recent Developments
9.3 Arcus Biosciences, Inc.
9.3.1 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Basic Information
9.3.2 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product Overview
9.3.3 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
9.3.4 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors SWOT Analysis
9.3.5 Arcus Biosciences, Inc. Business Overview
9.3.6 Arcus Biosciences, Inc. Recent Developments
9.4 Agenus Inc
9.4.1 Agenus Inc PD-1 and PDL-1 Inhibitors Basic Information
9.4.2 Agenus Inc PD-1 and PDL-1 Inhibitors Product Overview
9.4.3 Agenus Inc PD-1 and PDL-1 Inhibitors Product Market Performance
9.4.4 Agenus Inc Business Overview
9.4.5 Agenus Inc Recent Developments
9.5 F. Hoffmann-La Roche Ltd
9.5.1 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Basic Information
9.5.2 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Overview
9.5.3 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
9.5.4 F. Hoffmann-La Roche Ltd Business Overview
9.5.5 F. Hoffmann-La Roche Ltd Recent Developments
9.6 Astra Zeneca PLC
9.6.1 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Basic Information
9.6.2 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Overview
9.6.3 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Market Performance
9.6.4 Astra Zeneca PLC Business Overview
9.6.5 Astra Zeneca PLC Recent Developments
9.7 Beigene Ltd
9.7.1 Beigene Ltd PD-1 and PDL-1 Inhibitors Basic Information
9.7.2 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Overview
9.7.3 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
9.7.4 Beigene Ltd Business Overview
9.7.5 Beigene Ltd Recent Developments
9.8 Incyte Corporation
9.8.1 Incyte Corporation PD-1 and PDL-1 Inhibitors Basic Information
9.8.2 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Overview
9.8.3 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Market Performance
9.8.4 Incyte Corporation Business Overview
9.8.5 Incyte Corporation Recent Developments
9.9 Biocad
9.9.1 Biocad PD-1 and PDL-1 Inhibitors Basic Information
9.9.2 Biocad PD-1 and PDL-1 Inhibitors Product Overview
9.9.3 Biocad PD-1 and PDL-1 Inhibitors Product Market Performance
9.9.4 Biocad Business Overview
9.9.5 Biocad Recent Developments
9.10 CStone Pharmaceuticals
9.10.1 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Basic Information
9.10.2 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Overview
9.10.3 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Market Performance
9.10.4 CStone Pharmaceuticals Business Overview
9.10.5 CStone Pharmaceuticals Recent Developments
9.11 Ono Pharmaceutical
9.11.1 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Basic Information
9.11.2 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Overview
9.11.3 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Market Performance
9.11.4 Ono Pharmaceutical Business Overview
9.11.5 Ono Pharmaceutical Recent Developments
9.12 Merck
9.12.1 Merck PD-1 and PDL-1 Inhibitors Basic Information
9.12.2 Merck PD-1 and PDL-1 Inhibitors Product Overview
9.12.3 Merck PD-1 and PDL-1 Inhibitors Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 Shanghai Junshi Bioscience Co. Ltd
9.13.1 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Basic Information
9.13.2 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Overview
9.13.3 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
9.13.4 Shanghai Junshi Bioscience Co. Ltd Business Overview
9.13.5 Shanghai Junshi Bioscience Co. Ltd Recent Developments
9.14 Shanghai Henlius Biotech, Inc.
9.14.1 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Basic Information
9.14.2 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product Overview
9.14.3 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
9.14.4 Shanghai Henlius Biotech, Inc. Business Overview
9.14.5 Shanghai Henlius Biotech, Inc. Recent Developments
9.15 Jiangsu HengRui Medicine Co., Ltd.
9.15.1 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Basic Information
9.15.2 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product Overview
9.15.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product Market Performance
9.15.4 Jiangsu HengRui Medicine Co., Ltd. Business Overview
9.15.5 Jiangsu HengRui Medicine Co., Ltd. Recent Developments
10 PD-1 AND PDL-1 INHIBITORS MARKET FORECAST BY REGION
10.1 Global PD-1 and PDL-1 Inhibitors Market Size Forecast
10.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 and PDL-1 Inhibitors Market Size Forecast by Region
10.2.4 South America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PDL-1 Inhibitors by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 and PDL-1 Inhibitors Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 and PDL-1 Inhibitors by Type (2025-2030)
11.1.2 Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 and PDL-1 Inhibitors by Type (2025-2030)
11.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PD-1 and PDL-1 Inhibitors
1.2 Key Market Segments
1.2.1 PD-1 and PDL-1 Inhibitors Segment by Type
1.2.2 PD-1 and PDL-1 Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 AND PDL-1 INHIBITORS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-1 and PDL-1 Inhibitors Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 AND PDL-1 INHIBITORS MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-1 and PDL-1 Inhibitors Sales by Manufacturers (2019-2024)
3.2 Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PDL-1 Inhibitors Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-1 and PDL-1 Inhibitors Sales Sites, Area Served, Product Type
3.6 PD-1 and PDL-1 Inhibitors Market Competitive Situation and Trends
3.6.1 PD-1 and PDL-1 Inhibitors Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PDL-1 Inhibitors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 AND PDL-1 INHIBITORS INDUSTRY CHAIN ANALYSIS
4.1 PD-1 and PDL-1 Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-1 AND PDL-1 INHIBITORS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 AND PDL-1 INHIBITORS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2019-2024)
6.3 Global PD-1 and PDL-1 Inhibitors Market Size Market Share by Type (2019-2024)
6.4 Global PD-1 and PDL-1 Inhibitors Price by Type (2019-2024)
7 PD-1 AND PDL-1 INHIBITORS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PDL-1 Inhibitors Market Sales by Application (2019-2024)
7.3 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) by Application (2019-2024)
7.4 Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2024)
8 PD-1 AND PDL-1 INHIBITORS MARKET SEGMENTATION BY REGION
8.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PDL-1 Inhibitors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PDL-1 Inhibitors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PDL-1 Inhibitors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline plc
9.1.1 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Basic Information
9.1.2 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Overview
9.1.3 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Market Performance
9.1.4 GlaxoSmithKline plc Business Overview
9.1.5 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors SWOT Analysis
9.1.6 GlaxoSmithKline plc Recent Developments
9.2 Bristol-Myers Squibb Company
9.2.1 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Basic Information
9.2.2 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Overview
9.2.3 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Market Performance
9.2.4 Bristol-Myers Squibb Company Business Overview
9.2.5 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors SWOT Analysis
9.2.6 Bristol-Myers Squibb Company Recent Developments
9.3 Arcus Biosciences, Inc.
9.3.1 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Basic Information
9.3.2 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product Overview
9.3.3 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
9.3.4 Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors SWOT Analysis
9.3.5 Arcus Biosciences, Inc. Business Overview
9.3.6 Arcus Biosciences, Inc. Recent Developments
9.4 Agenus Inc
9.4.1 Agenus Inc PD-1 and PDL-1 Inhibitors Basic Information
9.4.2 Agenus Inc PD-1 and PDL-1 Inhibitors Product Overview
9.4.3 Agenus Inc PD-1 and PDL-1 Inhibitors Product Market Performance
9.4.4 Agenus Inc Business Overview
9.4.5 Agenus Inc Recent Developments
9.5 F. Hoffmann-La Roche Ltd
9.5.1 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Basic Information
9.5.2 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Overview
9.5.3 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
9.5.4 F. Hoffmann-La Roche Ltd Business Overview
9.5.5 F. Hoffmann-La Roche Ltd Recent Developments
9.6 Astra Zeneca PLC
9.6.1 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Basic Information
9.6.2 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Overview
9.6.3 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Market Performance
9.6.4 Astra Zeneca PLC Business Overview
9.6.5 Astra Zeneca PLC Recent Developments
9.7 Beigene Ltd
9.7.1 Beigene Ltd PD-1 and PDL-1 Inhibitors Basic Information
9.7.2 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Overview
9.7.3 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
9.7.4 Beigene Ltd Business Overview
9.7.5 Beigene Ltd Recent Developments
9.8 Incyte Corporation
9.8.1 Incyte Corporation PD-1 and PDL-1 Inhibitors Basic Information
9.8.2 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Overview
9.8.3 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Market Performance
9.8.4 Incyte Corporation Business Overview
9.8.5 Incyte Corporation Recent Developments
9.9 Biocad
9.9.1 Biocad PD-1 and PDL-1 Inhibitors Basic Information
9.9.2 Biocad PD-1 and PDL-1 Inhibitors Product Overview
9.9.3 Biocad PD-1 and PDL-1 Inhibitors Product Market Performance
9.9.4 Biocad Business Overview
9.9.5 Biocad Recent Developments
9.10 CStone Pharmaceuticals
9.10.1 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Basic Information
9.10.2 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Overview
9.10.3 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Market Performance
9.10.4 CStone Pharmaceuticals Business Overview
9.10.5 CStone Pharmaceuticals Recent Developments
9.11 Ono Pharmaceutical
9.11.1 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Basic Information
9.11.2 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Overview
9.11.3 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Market Performance
9.11.4 Ono Pharmaceutical Business Overview
9.11.5 Ono Pharmaceutical Recent Developments
9.12 Merck
9.12.1 Merck PD-1 and PDL-1 Inhibitors Basic Information
9.12.2 Merck PD-1 and PDL-1 Inhibitors Product Overview
9.12.3 Merck PD-1 and PDL-1 Inhibitors Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 Shanghai Junshi Bioscience Co. Ltd
9.13.1 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Basic Information
9.13.2 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Overview
9.13.3 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
9.13.4 Shanghai Junshi Bioscience Co. Ltd Business Overview
9.13.5 Shanghai Junshi Bioscience Co. Ltd Recent Developments
9.14 Shanghai Henlius Biotech, Inc.
9.14.1 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Basic Information
9.14.2 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product Overview
9.14.3 Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
9.14.4 Shanghai Henlius Biotech, Inc. Business Overview
9.14.5 Shanghai Henlius Biotech, Inc. Recent Developments
9.15 Jiangsu HengRui Medicine Co., Ltd.
9.15.1 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Basic Information
9.15.2 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product Overview
9.15.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product Market Performance
9.15.4 Jiangsu HengRui Medicine Co., Ltd. Business Overview
9.15.5 Jiangsu HengRui Medicine Co., Ltd. Recent Developments
10 PD-1 AND PDL-1 INHIBITORS MARKET FORECAST BY REGION
10.1 Global PD-1 and PDL-1 Inhibitors Market Size Forecast
10.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
10.2.3 Asia Pacific PD-1 and PDL-1 Inhibitors Market Size Forecast by Region
10.2.4 South America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PDL-1 Inhibitors by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-1 and PDL-1 Inhibitors Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-1 and PDL-1 Inhibitors by Type (2025-2030)
11.1.2 Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-1 and PDL-1 Inhibitors by Type (2025-2030)
11.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Application (2025-2030)
11.2.1 Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) Forecast by Application
11.2.2 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PDL-1 Inhibitors Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 and PDL-1 Inhibitors Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PDL-1 Inhibitors as of 2022)
Table 10. Global Market PD-1 and PDL-1 Inhibitors Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 and PDL-1 Inhibitors Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PDL-1 Inhibitors Product Type
Table 13. Global PD-1 and PDL-1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PDL-1 Inhibitors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PDL-1 Inhibitors Market Challenges
Table 22. Global PD-1 and PDL-1 Inhibitors Sales by Type (Kilotons)
Table 23. Global PD-1 and PDL-1 Inhibitors Market Size by Type (M USD)
Table 24. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 and PDL-1 Inhibitors Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 and PDL-1 Inhibitors Market Size Share by Type (2019-2024)
Table 28. Global PD-1 and PDL-1 Inhibitors Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) by Application
Table 30. Global PD-1 and PDL-1 Inhibitors Market Size by Application
Table 31. Global PD-1 and PDL-1 Inhibitors Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 and PDL-1 Inhibitors Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 and PDL-1 Inhibitors Market Share by Application (2019-2024)
Table 35. Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 and PDL-1 Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 and PDL-1 Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 and PDL-1 Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Basic Information
Table 44. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Overview
Table 45. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline plc Business Overview
Table 47. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 48. GlaxoSmithKline plc Recent Developments
Table 49. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Basic Information
Table 50. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Overview
Table 51. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 54. Bristol-Myers Squibb Company Recent Developments
Table 55. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Basic Information
Table 56. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product Overview
Table 57. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 59. Arcus Biosciences, Inc. Business Overview
Table 60. Arcus Biosciences, Inc. Recent Developments
Table 61. Agenus Inc PD-1 and PDL-1 Inhibitors Basic Information
Table 62. Agenus Inc PD-1 and PDL-1 Inhibitors Product Overview
Table 63. Agenus Inc PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Agenus Inc Business Overview
Table 65. Agenus Inc Recent Developments
Table 66. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 67. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 68. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Recent Developments
Table 71. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Basic Information
Table 72. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Overview
Table 73. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Astra Zeneca PLC Business Overview
Table 75. Astra Zeneca PLC Recent Developments
Table 76. Beigene Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 77. Beigene Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 78. Beigene Ltd PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Beigene Ltd Business Overview
Table 80. Beigene Ltd Recent Developments
Table 81. Incyte Corporation PD-1 and PDL-1 Inhibitors Basic Information
Table 82. Incyte Corporation PD-1 and PDL-1 Inhibitors Product Overview
Table 83. Incyte Corporation PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Incyte Corporation Business Overview
Table 85. Incyte Corporation Recent Developments
Table 86. Biocad PD-1 and PDL-1 Inhibitors Basic Information
Table 87. Biocad PD-1 and PDL-1 Inhibitors Product Overview
Table 88. Biocad PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Biocad Business Overview
Table 90. Biocad Recent Developments
Table 91. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Basic Information
Table 92. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Overview
Table 93. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CStone Pharmaceuticals Business Overview
Table 95. CStone Pharmaceuticals Recent Developments
Table 96. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Basic Information
Table 97. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Overview
Table 98. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Ono Pharmaceutical Business Overview
Table 100. Ono Pharmaceutical Recent Developments
Table 101. Merck PD-1 and PDL-1 Inhibitors Basic Information
Table 102. Merck PD-1 and PDL-1 Inhibitors Product Overview
Table 103. Merck PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Merck Business Overview
Table 105. Merck Recent Developments
Table 106. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 107. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 108. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Shanghai Junshi Bioscience Co. Ltd Business Overview
Table 110. Shanghai Junshi Bioscience Co. Ltd Recent Developments
Table 111. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Basic Information
Table 112. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product Overview
Table 113. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Shanghai Henlius Biotech, Inc. Business Overview
Table 115. Shanghai Henlius Biotech, Inc. Recent Developments
Table 116. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Basic Information
Table 117. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product Overview
Table 118. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Jiangsu HengRui Medicine Co., Ltd. Business Overview
Table 120. Jiangsu HengRui Medicine Co., Ltd. Recent Developments
Table 121. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific PD-1 and PDL-1 Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific PD-1 and PDL-1 Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa PD-1 and PDL-1 Inhibitors Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global PD-1 and PDL-1 Inhibitors Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PDL-1 Inhibitors Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-1 and PDL-1 Inhibitors Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PDL-1 Inhibitors as of 2022)
Table 10. Global Market PD-1 and PDL-1 Inhibitors Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-1 and PDL-1 Inhibitors Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PDL-1 Inhibitors Product Type
Table 13. Global PD-1 and PDL-1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PDL-1 Inhibitors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PDL-1 Inhibitors Market Challenges
Table 22. Global PD-1 and PDL-1 Inhibitors Sales by Type (Kilotons)
Table 23. Global PD-1 and PDL-1 Inhibitors Market Size by Type (M USD)
Table 24. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) by Type (2019-2024)
Table 25. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2019-2024)
Table 26. Global PD-1 and PDL-1 Inhibitors Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-1 and PDL-1 Inhibitors Market Size Share by Type (2019-2024)
Table 28. Global PD-1 and PDL-1 Inhibitors Price (USD/Ton) by Type (2019-2024)
Table 29. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) by Application
Table 30. Global PD-1 and PDL-1 Inhibitors Market Size by Application
Table 31. Global PD-1 and PDL-1 Inhibitors Sales by Application (2019-2024) & (Kilotons)
Table 32. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2019-2024)
Table 33. Global PD-1 and PDL-1 Inhibitors Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-1 and PDL-1 Inhibitors Market Share by Application (2019-2024)
Table 35. Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-1 and PDL-1 Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 37. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2019-2024)
Table 38. North America PD-1 and PDL-1 Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 41. South America PD-1 and PDL-1 Inhibitors Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Region (2019-2024) & (Kilotons)
Table 43. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Basic Information
Table 44. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Overview
Table 45. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. GlaxoSmithKline plc Business Overview
Table 47. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 48. GlaxoSmithKline plc Recent Developments
Table 49. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Basic Information
Table 50. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Overview
Table 51. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 54. Bristol-Myers Squibb Company Recent Developments
Table 55. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Basic Information
Table 56. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Product Overview
Table 57. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Arcus Biosciences, Inc. PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 59. Arcus Biosciences, Inc. Business Overview
Table 60. Arcus Biosciences, Inc. Recent Developments
Table 61. Agenus Inc PD-1 and PDL-1 Inhibitors Basic Information
Table 62. Agenus Inc PD-1 and PDL-1 Inhibitors Product Overview
Table 63. Agenus Inc PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Agenus Inc Business Overview
Table 65. Agenus Inc Recent Developments
Table 66. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 67. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 68. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. F. Hoffmann-La Roche Ltd Business Overview
Table 70. F. Hoffmann-La Roche Ltd Recent Developments
Table 71. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Basic Information
Table 72. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Overview
Table 73. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Astra Zeneca PLC Business Overview
Table 75. Astra Zeneca PLC Recent Developments
Table 76. Beigene Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 77. Beigene Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 78. Beigene Ltd PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Beigene Ltd Business Overview
Table 80. Beigene Ltd Recent Developments
Table 81. Incyte Corporation PD-1 and PDL-1 Inhibitors Basic Information
Table 82. Incyte Corporation PD-1 and PDL-1 Inhibitors Product Overview
Table 83. Incyte Corporation PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Incyte Corporation Business Overview
Table 85. Incyte Corporation Recent Developments
Table 86. Biocad PD-1 and PDL-1 Inhibitors Basic Information
Table 87. Biocad PD-1 and PDL-1 Inhibitors Product Overview
Table 88. Biocad PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Biocad Business Overview
Table 90. Biocad Recent Developments
Table 91. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Basic Information
Table 92. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Overview
Table 93. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. CStone Pharmaceuticals Business Overview
Table 95. CStone Pharmaceuticals Recent Developments
Table 96. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Basic Information
Table 97. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Overview
Table 98. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Ono Pharmaceutical Business Overview
Table 100. Ono Pharmaceutical Recent Developments
Table 101. Merck PD-1 and PDL-1 Inhibitors Basic Information
Table 102. Merck PD-1 and PDL-1 Inhibitors Product Overview
Table 103. Merck PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Merck Business Overview
Table 105. Merck Recent Developments
Table 106. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 107. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 108. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Shanghai Junshi Bioscience Co. Ltd Business Overview
Table 110. Shanghai Junshi Bioscience Co. Ltd Recent Developments
Table 111. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Basic Information
Table 112. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Product Overview
Table 113. Shanghai Henlius Biotech, Inc. PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Shanghai Henlius Biotech, Inc. Business Overview
Table 115. Shanghai Henlius Biotech, Inc. Recent Developments
Table 116. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Basic Information
Table 117. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Product Overview
Table 118. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PDL-1 Inhibitors Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Jiangsu HengRui Medicine Co., Ltd. Business Overview
Table 120. Jiangsu HengRui Medicine Co., Ltd. Recent Developments
Table 121. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific PD-1 and PDL-1 Inhibitors Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific PD-1 and PDL-1 Inhibitors Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa PD-1 and PDL-1 Inhibitors Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global PD-1 and PDL-1 Inhibitors Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PD-1 and PDL-1 Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PDL-1 Inhibitors Market Size (M USD), 2019-2030
Figure 5. Global PD-1 and PDL-1 Inhibitors Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PDL-1 Inhibitors Market Size by Country (M USD)
Figure 11. PD-1 and PDL-1 Inhibitors Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PDL-1 Inhibitors Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PDL-1 Inhibitors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PDL-1 Inhibitors Market Share by Type
Figure 18. Sales Market Share of PD-1 and PDL-1 Inhibitors by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 and PDL-1 Inhibitors by Type in 2023
Figure 20. Market Size Share of PD-1 and PDL-1 Inhibitors by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 and PDL-1 Inhibitors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PDL-1 Inhibitors Market Share by Application
Figure 24. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PDL-1 Inhibitors Market Share by Application (2019-2024)
Figure 27. Global PD-1 and PDL-1 Inhibitors Market Share by Application in 2023
Figure 28. Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 and PDL-1 Inhibitors Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 and PDL-1 Inhibitors Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 and PDL-1 Inhibitors Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 and PDL-1 Inhibitors Sales Market Share by Region in 2023
Figure 44. China PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 and PDL-1 Inhibitors Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 and PDL-1 Inhibitors Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 and PDL-1 Inhibitors Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 and PDL-1 Inhibitors Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of PD-1 and PDL-1 Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PDL-1 Inhibitors Market Size (M USD), 2019-2030
Figure 5. Global PD-1 and PDL-1 Inhibitors Market Size (M USD) (2019-2030)
Figure 6. Global PD-1 and PDL-1 Inhibitors Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PDL-1 Inhibitors Market Size by Country (M USD)
Figure 11. PD-1 and PDL-1 Inhibitors Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PDL-1 Inhibitors Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PDL-1 Inhibitors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PDL-1 Inhibitors Market Share by Type
Figure 18. Sales Market Share of PD-1 and PDL-1 Inhibitors by Type (2019-2024)
Figure 19. Sales Market Share of PD-1 and PDL-1 Inhibitors by Type in 2023
Figure 20. Market Size Share of PD-1 and PDL-1 Inhibitors by Type (2019-2024)
Figure 21. Market Size Market Share of PD-1 and PDL-1 Inhibitors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PDL-1 Inhibitors Market Share by Application
Figure 24. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2019-2024)
Figure 25. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PDL-1 Inhibitors Market Share by Application (2019-2024)
Figure 27. Global PD-1 and PDL-1 Inhibitors Market Share by Application in 2023
Figure 28. Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2019-2024)
Figure 30. North America PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada PD-1 and PDL-1 Inhibitors Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico PD-1 and PDL-1 Inhibitors Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific PD-1 and PDL-1 Inhibitors Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific PD-1 and PDL-1 Inhibitors Sales Market Share by Region in 2023
Figure 44. China PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America PD-1 and PDL-1 Inhibitors Sales and Growth Rate (Kilotons)
Figure 50. South America PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-1 and PDL-1 Inhibitors Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-1 and PDL-1 Inhibitors Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Application (2025-2030)
Figure 66. Global PD-1 and PDL-1 Inhibitors Market Share Forecast by Application (2025-2030)
